AIMS: Prevalent right ventricular (RV) dysfunction (RVD) is associated with increased mortality in patients with heart failure with preserved ejection fraction (HFpEF), but no study has characterized long-term changes in RV structure and function within the same patient. METHODS AND RESULTS: Patients with unequivocal HFpEF defined by either invasive haemodynamics or hospitalization for pulmonary oedema (n = 271) underwent serial echocardiographic evaluations >6 months apart. Clinical, structural, functional, and haemodynamic characteristics were examined. Over a median of 4.0 years (interquartile range 2.1-6.1), there was a 10% decline in RV fractional area change and 21% increase in RV diastolic area (both P < 0.0001). These changes greatly exceeded corresponding changes in the left ventricle. The prevalence of tricuspid regurgitation increased by 45%. Of 238 patients with normal RV function at Exam 1, 55 (23%) developed RVD during follow-up. Development of RVD was associated with both prevalent and incident atrial fibrillation (AF), higher body weight, coronary disease, higher pulmonary artery and left ventricular filling pressures, and RV dilation. Patients with HFpEF developing incident RVD had nearly two-fold increased risk of death (adjusted hazard ratio 1.89, 95% confidence interval 1.01-3.44; P = 0.04). CONCLUSION: While previous attention has centred on the left ventricle in HFpEF, these data show that right ventricular structure and function deteriorate to greater extent over time when compared with changes in the left ventricle. Further study is required to evaluate whether interventions targeting modifiable risk factors identified for incident RVD, including abnormal haemodynamics, AF, coronary disease, and obesity, can prevent RVD and thus improve outcomes. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: Prevalent right ventricular (RV) dysfunction (RVD) is associated with increased mortality in patients with heart failure with preserved ejection fraction (HFpEF), but no study has characterized long-term changes in RV structure and function within the same patient. METHODS AND RESULTS:Patients with unequivocal HFpEF defined by either invasive haemodynamics or hospitalization for pulmonary oedema (n = 271) underwent serial echocardiographic evaluations >6 months apart. Clinical, structural, functional, and haemodynamic characteristics were examined. Over a median of 4.0 years (interquartile range 2.1-6.1), there was a 10% decline in RV fractional area change and 21% increase in RV diastolic area (both P < 0.0001). These changes greatly exceeded corresponding changes in the left ventricle. The prevalence of tricuspid regurgitation increased by 45%. Of 238 patients with normal RV function at Exam 1, 55 (23%) developed RVD during follow-up. Development of RVD was associated with both prevalent and incident atrial fibrillation (AF), higher body weight, coronary disease, higher pulmonary artery and left ventricular filling pressures, and RV dilation. Patients with HFpEF developing incident RVD had nearly two-fold increased risk of death (adjusted hazard ratio 1.89, 95% confidence interval 1.01-3.44; P = 0.04). CONCLUSION: While previous attention has centred on the left ventricle in HFpEF, these data show that right ventricular structure and function deteriorate to greater extent over time when compared with changes in the left ventricle. Further study is required to evaluate whether interventions targeting modifiable risk factors identified for incident RVD, including abnormal haemodynamics, AF, coronary disease, and obesity, can prevent RVD and thus improve outcomes. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Selma F Mohammed; Imad Hussain; Omar F AbouEzzeddine; Omar F Abou Ezzeddine; Hiroyuki Takahama; Susan H Kwon; Paul Forfia; Véronique L Roger; Margaret M Redfield Journal: Circulation Date: 2014-11-12 Impact factor: 29.690
Authors: Masaru Obokata; Yogesh N V Reddy; Vojtech Melenovsky; Garvan C Kane; Thomas P Olson; Petr Jarolim; Barry A Borlaug Journal: J Am Coll Cardiol Date: 2018-07-03 Impact factor: 24.094
Authors: Thomas M Gorter; Dirk J van Veldhuisen; Adriaan A Voors; Yoran M Hummel; Carolyn S P Lam; Rolf M F Berger; Joost P van Melle; Elke S Hoendermis Journal: Eur Heart J Cardiovasc Imaging Date: 2018-04-01 Impact factor: 6.875
Authors: Thomas M Gorter; Dirk J van Veldhuisen; Johann Bauersachs; Barry A Borlaug; Jelena Celutkiene; Andrew J S Coats; Marisa G Crespo-Leiro; Marco Guazzi; Veli-Pekka Harjola; Stephane Heymans; Loreena Hill; Mitja Lainscak; Carolyn S P Lam; Lars H Lund; Alexander R Lyon; Alexandre Mebazaa; Christian Mueller; Walter J Paulus; Burkert Pieske; Massimo F Piepoli; Frank Ruschitzka; Frans H Rutten; Petar M Seferovic; Scott D Solomon; Sanjiv J Shah; Filippos Triposkiadis; Rolf Wachter; Carsten Tschöpe; Rudolf A de Boer Journal: Eur J Heart Fail Date: 2017-10-16 Impact factor: 15.534
Authors: Michael A Burke; Daniel H Katz; Lauren Beussink; Senthil Selvaraj; Deepak K Gupta; Justin Fox; Sudarsana Chakrabarti; Andrew J Sauer; Jonathan D Rich; Benjamin H Freed; Sanjiv J Shah Journal: Circ Heart Fail Date: 2013-12-23 Impact factor: 8.790
Authors: Dalane W Kitzman; Peter Brubaker; Timothy Morgan; Mark Haykowsky; Gregory Hundley; William E Kraus; Joel Eggebeen; Barbara J Nicklas Journal: JAMA Date: 2016-01-05 Impact factor: 56.272
Authors: Yogesh N V Reddy; Masaru Obokata; Brandon Wiley; Katlyn E Koepp; Caitlin C Jorgenson; Alexander Egbe; Vojtech Melenovsky; Rickey E Carter; Barry A Borlaug Journal: Eur Heart J Date: 2019-12-01 Impact factor: 29.983
Authors: Jakob Ledwoch; Carmen Fellner; Petra Hoppmann; Ruth Thalmann; Hans Kossmann; Michael Dommasch; Ralf Dirschinger; Anja Stundl; Karl-Ludwig Laugwitz; Christian Kupatt Journal: Int J Cardiovasc Imaging Date: 2020-01-13 Impact factor: 2.357
Authors: Jennifer E Ho; Margaret M Redfield; Gregory D Lewis; Walter J Paulus; Carolyn S P Lam Journal: Circulation Date: 2020-11-02 Impact factor: 29.690
Authors: Masaru Obokata; Garvan C Kane; Yogesh N V Reddy; Vojtech Melenovsky; Thomas P Olson; Petr Jarolim; Barry A Borlaug Journal: Eur Heart J Date: 2019-12-01 Impact factor: 29.983
Authors: Yogesh N V Reddy; Masaru Obokata; Frederik H Verbrugge; Grace Lin; Barry A Borlaug Journal: J Am Coll Cardiol Date: 2020-09-01 Impact factor: 24.094
Authors: Sanjiv J Shah; Barry A Borlaug; Dalane W Kitzman; Andrew D McCulloch; Burns C Blaxall; Rajiv Agarwal; Julio A Chirinos; Sheila Collins; Rahul C Deo; Mark T Gladwin; Henk Granzier; Scott L Hummel; David A Kass; Margaret M Redfield; Flora Sam; Thomas J Wang; Patrice Desvigne-Nickens; Bishow B Adhikari Journal: Circulation Date: 2020-03-23 Impact factor: 29.690
Authors: Katlyn E Koepp; Masaru Obokata; Yogesh N V Reddy; Thomas P Olson; Barry A Borlaug Journal: JACC Heart Fail Date: 2020-07-08 Impact factor: 12.035